NCT03253666 Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) Status COMPLETED Phase N/A
NCT03252340 Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis Status COMPLETED Phase N/A
NCT03250624 Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03245385 Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT03198390 Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions Status TERMINATED Phase N/A
NCT03160885 Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) Status COMPLETED Phase PHASE3
NCT03157284 Efficacy of Fermented Rice Flour for the Treatment of Atopic Dermatitis Status COMPLETED Phase NA
NCT03142139 Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age? Status COMPLETED Phase N/A
NCT03131648 Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) Status COMPLETED Phase PHASE3
NCT03107611 Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03091426 Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03089476 Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy Status WITHDRAWN Phase NA
NCT03089229 A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis Status COMPLETED Phase PHASE1/PHASE2
NCT03083730 Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis Status COMPLETED Phase NA
NCT03058783 Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects Status COMPLETED Phase PHASE3
NCT03051958 Internet-based Mindfulness and Exposure Treatment for Atopic Dermatitis Status COMPLETED Phase NA